These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 617780)

  • 41. [Participation of sialic acid residue in the fibrinogen-fibrin conversion by thrombin].
    Akihama S; Matsuda Y; Fukase T; Yamanaka A; Okude M
    Yakugaku Zasshi; 1995 Jul; 115(7):537-42. PubMed ID: 7562401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
    Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The intravascular generation of fibrinogen derivatives and the blood vessel wall in venous thrombosis and disseminated intravascular coagulation.
    Stewart GJ
    Thromb Haemost; 1977 Dec; 38(4):831-49. PubMed ID: 146274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma D-dimer levels and their relationship to serum fibrinogen/fibrin degradation products in hypercoagulable states.
    Wilde JT; Kitchen S; Kinsey S; Greaves M; Preston FE
    Br J Haematol; 1989 Jan; 71(1):65-70. PubMed ID: 2917130
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An immunohistochemical study of experimental disseminated intravascular coagulation (DIC).
    Toyofuku H; Hayashi K; Awai M
    Acta Pathol Jpn; 1987 Aug; 37(8):1279-90. PubMed ID: 3314332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
    Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
    Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Fibrinogen derivatives appearing in calf plasma after the action of thrombin and endotoxin].
    Benabid Y; Laurent M; Concord E; Suscillon M
    Pathol Biol (Paris); 1973 Nov; 21():Suppl:24-30. PubMed ID: 4587012
    [No Abstract]   [Full Text] [Related]  

  • 48. Occurrence of soluble very high molecular weight fibrinogen complexes in hypercoagulable states. An in vitro and in vivo study on their features.
    Neri Serneri GG; Gensini GF; Abbate R; Favilla S
    Thromb Haemost; 1980 Feb; 42(5):1561-73. PubMed ID: 6768154
    [No Abstract]   [Full Text] [Related]  

  • 49. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
    Okude M; Yamanaka A; Morimoto Y; Akihama S
    Biol Pharm Bull; 1993 May; 16(5):448-52. PubMed ID: 8364489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of heparin on fibrinogen formation during experimental toxic syndrome of disseminated intravascular coagulation].
    Barkagan ZS; Momot AP; Glazunova GA; Taranina TS; Koltakova SI
    Ukr Biokhim Zh (1978); 1988; 60(1):23-9. PubMed ID: 3363673
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isolation and purification of fibrinogen/fibrin degradation products by chromatography on protamine-agarose.
    Dempfle CE; Heene DL
    Thromb Res; 1987 Oct; 48(2):223-32. PubMed ID: 3424289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Heene DL; Genth K
    Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
    [No Abstract]   [Full Text] [Related]  

  • 53. [A test for the detection of fibrin in the plasma].
    Franke M; Hafter R; von Hugo R; Röbl M; Graeff H
    Geburtshilfe Frauenheilkd; 1986 Feb; 46(2):105-9. PubMed ID: 3956964
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Meningococcemia and disseminated intravascular coagulation (DIC). Reports of 2 cases].
    Nielsen G; Simonsen EE; Schmidt KG
    Ugeskr Laeger; 1974 May; 136(21):1156-8. PubMed ID: 4839964
    [No Abstract]   [Full Text] [Related]  

  • 55. Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit.
    Bateman SW; Mathews KA; Abrams-Ogg AC; Lumsden JH; Johnstone IB; Hillers TK; Foster RA
    J Am Vet Med Assoc; 1999 Sep; 215(6):798-804. PubMed ID: 10496131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human factor XIII: fibrin-stabilizing factor.
    Lorand L; Losowsky MS; Miloszewski KJ
    Prog Hemost Thromb; 1980; 5():245-90. PubMed ID: 7422874
    [No Abstract]   [Full Text] [Related]  

  • 57. Hemostatic molecular markers before the onset of disseminated intravascular coagulation.
    Wada H; Sakuragawa N; Mori Y; Takagi M; Nakasaki T; Shimura M; Hiyoyama K; Nisikawa M; Gabazza EC; Deguchi K; Kazama M; Shiku H
    Am J Hematol; 1999 Apr; 60(4):273-8. PubMed ID: 10203100
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Determination of the rate of microthrombosis in experimentally induced disseminated intravascular coagulation (DIC)].
    Nowak G; Hoffmann J; Markwardt F
    Acta Biol Med Ger; 1976; 35(11):K63-K68. PubMed ID: 1022125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of fibrinogen degradation products on the reptilase-time of plasma.
    Arnesen H; Kierulf P; Godal HC
    Scand J Haematol; 1973; 11(5):360-6. PubMed ID: 4798341
    [No Abstract]   [Full Text] [Related]  

  • 60. Measurement of cross linked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies.
    Whitaker AN; Elms MJ; Masci PP; Bundesen PG; Rylatt DB; Webber AJ; Bunce IH
    J Clin Pathol; 1984 Aug; 37(8):882-7. PubMed ID: 6206097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.